InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,900.01
(
-0.42%
)
Post# of 43292
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: None

Friday, 11/13/2020 7:45:31 AM

Friday, November 13, 2020 7:45:31 AM

Post# of 43292
AZN- another potential HGEN lenzilumab competitor fails -


AstraZeneca Cancer Drug Fails to Help Patients With Covid-19
By Marthe Fourcade
November 12, 2020, 2:29 AM EST
AstraZeneca Plc said its blood-cancer medicine Calquence failed to help patients hospitalized with respiratory symptoms of Covid-19.

The group of patients taking the drug in addition to standard care didn’t show fewer deaths or respiratory failures, the U.K. drugmaker said in a statement. Details of the intermediate clinical trials will be presented in due course, the company said.

https://www.google.com/amp/s/www.bloomberg.com/amp/news/articles/2020-11-12/astrazeneca-cancer-drug-fails-to-help-patients-with-covid-19
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up